The child was diagnosed with warm-antibody AIHA and started on prednisone 2 mg/kg/day. She responded quickly to therapy; within one week hemoglobin was 91 g/L and reticulocytes 667x10 9 /L. Physical examination revealed that both liver and spleen were smaller. By December 1993 the patient was well, with a hemoglobin level of 111 g/L. By March 1994 she had been weaned off steroids.
Although the patient was free from hemolysis she continued to have hepatomegaly. Between June and September 1994, her spleen enlarged massively until it was palpable near the left iliac crest. In November 1994, following the first episode of hemolysis since presentation, she was transfused and started on prednisone. At that time liver function tests were aspartate aminotransferase (AST) 302 U/L (normal less than 45 U/L); alanine aminotransferase (ALT) 589 U/L (less than 45 U/L); and alkaline phosphatase 487 U/L (185 to 520 U/L). One month later abdominal sonography showed mild hepatosplenomegaly with mild dilation of intrahepatic bile ducts and a widened common bile duct, but no cholelithiasis or choledocholithiasis.
In February 1995 the patient presented with a 12-day history of bright red blood mixed with stool occurring two to three times/day. There was no night-time stooling, urgency, abdominal pain, fever or vomiting. The patient's mother indicated that hematochezia had occurred intermittently during the previous 15 months. Stool cultures for bacteria, viruses and parasites were negative, as was a Meckel scan. Further investigations were consistent with UC. Colonoscopy revealed a diffusely friable mucosa up to the ascending colon. Colonic biopsies showed mild to moderate inflammation with inflammatory cells within the lamina propria, and focal areas of pericryptitis. The patient was started on sulphasalazine. Percutaneous liver biopsy revealed chronic hepatitis with marked piecemeal necrosis, extensive ductular proliferation and moderate cholangitis (Figure 1 ). Percutaneous cholangiogram showed irregular intrahepatic ducts with 'pruning' of the ducts, thus confirming the diagnosis of PSC (Figure 2 ).
DISCUSSION
A unique triad of AIHA, UC and PSC is seen in our patient. The association between UC and PSC, and between UC and AIHA is well known. PSC is found in 3% to 7% of adult UC patients (3). Conversely, 70% of adult PSC patients have UC (4). AIHA has been reported in 0.5% to 1.0% of adult UC patients, but there are only two cases in the literature of AIHA and PSC (2, 5, 6) . The constellation of UC, PSC and AIHA has never been reported.
PSC is not uncommon in children and may be associated with colitis (4,7). Children with PSC may be more difficult to identify for several reasons. First, the association between UC and PSC is lower in children; in the largest North American series, only 55% had inflammatory bowel disease and half of these developed it after onset of PSC (4). Second, PSC in children differs from that in adults; PSC in children frequently is limited to intrahepatic bile ducts. Thus, presentation with jaundice and increased ALP is less common than in adults. Finally, PSC in children is diagnosed on the basis of cholangiographic findings: strictures, or dilation or irregu-
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Figure 1) Percutaneous liver biopsy in a patient with ulcerative colitis and hepatomegaly of 16 months' duration. Note wide area of scarring in which there is a mild chronic inflammatory infiltrate seen. Note also extensive piecemeal necrosis. Hematoxylin and eosin stain x98
Figure 2) Percutaneous transhepatic cholangiogram demonstrating a normal extrahepatic ductal system (a) with involvement of the medium and small ducts of both left and right lobes (b). Features include irregularity of the walls with areas of dilation and stenosis. Contrast fills the cystic ducts (c) and duodenum (d)
larities of the intra-or extrahepatic bile ducts. Elevated serum IgG and positive antismooth muscle and antinuclear antibodies occur commonly in children with PSC, and liver histology often has features suggestive of autoimmune hepatitis (4, 8) . Whether PSC mimics autoimmune hepatitis or both are manifestations of a single disease process causing autoimmune hepatic disease remains uncertain.
Immunological abnormalities are important in the pathogenesis of PSC and UC. Both conditions have been associated with elevated immunoglobulins, with abnormal autoantibodies against liver cells in PSC and against colonic epithelium in UC (9, 10) . Immunosuppressive therapy, such as prednisone and cyclosporine, is effective in UC (11) . AIHA results from impaired immunoregulation. Recent in vitro work in AIHA indicates that colonic mononuclear cells may be the origin of the red cell antibodies when AIHA is associated with UC (12). Some patients have had resolution of anemia with colectomy, thereby indicating that the colon may be associated with the production of anti-erythrocyte antibodies (13) . Because PSC may progress after colectomy, such a similar causal relationship has not been established between colonic disease and PSC.
CONCLUSIONS
We report a child with AIHA, UC and PSC. While there have been only two previous reports of the association of AIHA and PSC, and one report of AIHA, Crohn's disease and PSC, all three conditions have the features of impaired immunoregulation (5, 6, 14) . Abnormal activation of the humoral immune system is common to all these disorders. Patients who present with unique combinations of these autoimmune conditions, as did our reported child, provide important clues to the pathogenesis of UC.
